BriaCell Therapeutics Corp. Share Price
BCTXBriaCell Therapeutics Corp. Stock Performance
Open $4.25 | Prev. Close $4.51 | Circuit Range N/A |
Day Range $4.25 - $4.55 | Year Range $0.61 - $13.78 | Volume 8,431 |
Average Traded $4.46 |
BriaCell Therapeutics Corp. Share Price Chart
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
BriaCell Therapeutics Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
21-Jan-26 | $4.38 | $4.23 | -3.20% |
20-Jan-26 | $4.19 | $4.37 | +1.51% |
16-Jan-26 | $4.42 | $4.30 | -4.44% |
15-Jan-26 | $4.77 | $4.50 | -7.30% |
14-Jan-26 | $4.78 | $4.86 | -56.41% |
13-Jan-26 | $12.10 | $11.15 | +45.09% |
12-Jan-26 | $7.32 | $7.68 | +7.48% |